MetLife Investment Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181K | Hold |
46,870
| – | – | ﹤0.01% | 2246 |
|
|
2025
Q1 | $234K | Buy |
46,870
+2,396
| +5% | +$12K | ﹤0.01% | 2116 |
|
|
2024
Q4 | $321K | Buy |
44,474
+2,897
| +7% | +$20.9K | ﹤0.01% | 2035 |
|
|
2024
Q3 | $255K | Hold |
41,577
| – | – | ﹤0.01% | 2158 |
|
|
2024
Q2 | $276K | Buy |
41,577
+15,262
| +58% | +$101K | ﹤0.01% | 2044 |
|
|
2024
Q1 | $268K | Hold |
26,315
| – | – | ﹤0.01% | 2028 |
|
|
2023
Q4 | $296K | Hold |
26,315
| – | – | ﹤0.01% | 2012 |
|
|
2023
Q3 | $68.4K | Hold |
26,315
| – | – | ﹤0.01% | 2770 |
|
|
2023
Q2 | $92.9K | Buy |
+26,315
| New | +$92.9K | ﹤0.01% | 2723 |
|
|
2022
Q2 | – | Sell |
-21,184
| Closed | -$129K | – | 2857 |
|
|
2022
Q1 | $129K | Buy |
21,184
+8,385
| +66% | +$51.1K | ﹤0.01% | 2569 |
|
|
2021
Q4 | $117K | Hold |
12,799
| – | – | ﹤0.01% | 2351 |
|
|
2021
Q3 | $145K | Hold |
12,799
| – | – | ﹤0.01% | 2268 |
|
|
2021
Q2 | $126K | Buy |
+12,799
| New | +$126K | ﹤0.01% | 2383 |
|